| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Methylphenidate | FAERS: 7 | US FAERS | |
| 2 | Hydrocortisone | FAERS: 6 | US FAERS | |
| 3 | Octreotide | FAERS: 4 | US FAERS | |
| 4 | Fluticasone | FAERS: 3 | US FAERS | |
| 5 | Isotretinoin | FAERS: 2 | US FAERS | |
| 6 | Lenalidomide | FAERS: 2 | US FAERS | |
| 7 | Teriparatide | FAERS: 2 | US FAERS | |
| 8 | Finasteride | FAERS: 1 | US FAERS | |
| 9 | Fluticasone-Salmeterol Drug Combination | FAERS: 1 | US FAERS | |
| 10 | Risperidone | FAERS: 1 | US FAERS | |
| 11 | hydrocortisone-17-butyrate | FAERS: 1 | US FAERS | |
| 12 | lanreotide | FAERS: 1 | US FAERS | |
| 13 | Calcitriol | OFFSIDES | ||
| 14 | Cytarabine | OFFSIDES | ||
| 15 | Mercaptopurine | OFFSIDES | ||
| 16 | Salmeterol Xinafoate | OFFSIDES | ||
| 17 | Thioguanine | OFFSIDES | ||
| 18 | montelukast | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.